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Receptors for the Fc portion of Igs were first identified on lymphocytes in 1970
(1), andlaterdifferentiated onthe basis oftheirselective affinityforvarious Igclasses.
Fc receptors for IgE (FcsR) are found on a variety of human (2, 3) and rodent (4)
cells and can be categorized on the basis oftheir affinity for IgE. High-affinity FcCR
(FcsR-I) found on mast cells and basophils (5) clearly mediate allergic degranula-
tion. However, the moderate-affinity FcsR (FcsR-II) present on macrophage/mono-
cytes (6), eosinophils (7), and lymphocytes (2, 8) is lesswell characterized. The role
that lymphocyte FcsRII plays in the regulation ofthe immune system is the object
ofmuch recent study (9-22). Current evidence supports a model whereby the inter-
action between IgE and its receptor initiates a cascade of events that give rise to
increased FcsR expression and, ultimately, control of IgE production.
However, little is known ofthe consequences ofIgE-FcsR interaction as they apply
to events that are not directly involved with IgE regulation, such as modulation of
other surface moleculeson FcsRbearingcells. Indeed, the surprisingly highnumbers
ofFcsR+ lymphocytes, including at least 50% of B cells from BALB/c mouse spleen
(23), suggest that the IgE system might participate in immune regulation outside
of the limited role to which it has been traditionally ascribed. Additionally, little
attentionhas been directed tothe influenceofantigen-mediated crosslinking ofFcsR
bound IgE molecules particularly as it relates to the role(s) of FcsR+ B cells in an
immune response. One report on murine macrophages showed that immune com-
plexes of IgG or IgE inhibit IFN-y-mediated induction of class II antigens ofthe
MHC (24).
Herein we presentdatathat demonstrate that the efficiency withwhich monoclonal
IgE binds to and enhances the expression ofB cell FcsR is substantially increased
when IgE is complexed with specific antigen. More importantly, we report for the
first time that soluble IgE-antigen complexes potently stimulate the cell surface ex-
pression of B cell class II MHC (Ia) antigens, while IgE alone (in the absence of
antigen) has little effect. This enhancement oflaexpression suggeststhat IgE-antigen
complexes may play a more generalized role in immune responses than previously
assumed.
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Materials and Methods
Animals.
￿
All assays were performed with spleen cells from male BALB/c mice, aged 8-12
wk. Hybridoma ascites were obtained from 12-16-wk-old male (BALB/c x A/J)Fj (CAF,)
mice. Both mouse strains were obtained from the breeding colonies of the Medical Biology
Institute.
Reagents.
￿
BSA, Ficoll (Histopaque), 2-ME, and propidium iodide were obtained from
Sigma Chemical Co. (St. Louis, MO). NP-40 was purchased from Bethesda Research Labora-
tories (Rockville, MD). FITC-avidin conjugates and OVA were purchased from Miles Labora-
tories, Inc. (Elkhart, IN). The conjugates of 2,4-dinitrophenyl-ovalbumin (DNP15-OVA) and
DNPII-BSA were prepared as described (25). CNBr-activated Sepharose 4B was acquired
from Pharmacia Fine Chemicals (Uppsala, Sweden). Guinea pig complement (Pel-Freeze
Biologicals, Rogers, AR) was adsorbed at 4°C with BALB/c spleen cells before use. [3H]TdR
was purchased from New England Nuclear (Boston, MA).
Antibodies.
￿
FITC-conjugated and unconjugated goat anti-mouse IgG were obtained from
Cappel Laboratories (Malvern, PA). FITC-goat anti-mouse IgM was purchased from Fisher
Scientific Co. (Orangeburg, NY). Anti-DNP IgE and anti-DNP IgG mAbs were affinity
purified from mouse ascites according to the methods described by Liu et al. (25). Iodination
of IgE was accomplished using the chloramineT method. Monoclonal antiThy-1.2 was de-
rived from F7D5e7 hybridoma clone (26), obtained as ascites, and clarified by centrifuga-
tion. Anti-I-A', anti-I-Ad, and anti-I-E antibodies were obtained from 10.3.6, MKD6, and
14.4.4 hybridomas, respectively, and purified from mouse ascites. Biotinylated 10.3.6, MKD6,
and 14.4.4 antibodies were kindly provided by Dr. Carol Cowing, Medical Biology Institute.
Anti-class I antibodies (anti-KdDd, 34-1-2S; anti-Dd, 34-5-8S) were provided as culture su-
pernatants by Dr. Matthew Mescher, Medical Biology Institute. Goat anti-mouse IgE
(GAME)' antibodies were prepared and purified as described previously (25). Goat anti-
mouse IgM antibody and biotinylated anti-IgMb (mouse IgGJ, AF6-78.25) were gifts from
Dr. Donald Mosier, Medical Biology Institute.
Induction of FceR and Surface Ia (sla) in Lymphoid Cells.
￿
BALB/c mouse spleen cells were
dispersed in MEM (MA Bioproducts, Walkersville, MD) usinga tissue grinder, and washed
twice in MEM. Red blood cells were eliminated by treating the dispersed spleen cells with
ammonium chloride solution for 5 min followed by two washes in MEM. T cell depletion
was performed by incubating the cells with antiThy-1.2 mAb, followed by guinea pig comple-
ment, as described (27). Macrophage depletion was accomplished by passage ofT cell-depleted
lymphocytes over Sephadex G-10 (28). Lymphocytes were cultured with the indicated inducing
substance in DME (MA Bioproducts), 1017c FCS (HyClone Laboratories, Logan, UT), 100
U/ml penicillin, and 100,gg/ml streptomycin (DME-FCS) at a concentration of 107/ml in
0.5 ml aliquots in 24-well culture plates (Costar, Cambridge, MA). Incubations were carried
out in a humidified 10% C02 enviroment maintained at 37°C for 18-24 h, unless indicated
otherwise.
FceR Labeling Assay.
￿
In previous studies we have used a rosette assay to detect nascent
and induced FceR molecules on mouse lymphocytes (19). In this study, a more quantitative,
less cumbersome assay has been developed using ' 251gE to label FceR sites, thus permitting
characterization of the ligand-receptor interaction. Nascent FceR molecules expressed on
freshly isolated BALB/c spleen cells were quantitated by exposing splenocytes to cold mono-
meric IgE (in varying concentrations) containing 1251-labeled IgE as tracer in the absence
or presence of varying quantities of DNP-OVA. All labeling exposures were carried out at
4°C in PBS containing 0.1% NaN3 plus 0.1% BSA (PAB) in a final volume of 200 111 (5 x
106 cells) for 2 h. When quantitating FceR on lymphocytes harvested from induction cul-
tures, cell-bound IgE on unfractionated or T lymphocyte-depleted spleen cells was first re-
moved by acid elution (see Results) before labeling. After the 2-h incubation at 4°C, labeled
cells were centrifuged over 85% dibutyl phthalate/15% mineral oil and radioactivity of the
pellet was quantitated. The cpm of cell-associated '25I-IgE was determined in the presence
' Abbreviations used in thispaper . GAME, goat anti-mouse IgE; MFI, mean fluorescence intensity, PAB,
PBS containing azide and BSA.RICHARDS ET AL.
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of200 gg/ml ofunlabeled IgE and subtracted from all experimental values. All samples were
tested in duplicate or triplicate, and the experiments were repeated with similar results. The
data were most reproducible when 1251-IgE tracer was coincubated with near-saturating con-
centrations of unlabeled IgE (5-40 gg/ml). This minimized rebinding of the radiolabel and
other kinetic idiosyncracies that might have distorted interpretation ofthe results. The results
obtained with this method were qualitatively comparable to the rosette assay.
Measurement ofCell Surface I-A andI-E Antigens.
￿
Preincubated B cells were washed in MEM,
reconstituted in 3 ml DME-FCS and centrifuged over Ficoll (specific gravity 1.090) at 2,000
rpm for 20 min. Cells at the interface were collected, washed twice and reconstituted in HBSS
(MA Bioproducts) plus 0.1% NaN3 and 0.1% BSA. 106 cells (in 100 ul) were incubated with
2 ug biotinylated anti-I-Ad (MKD6) or anti-I-Ed (14.4.4) antibodies for 30 min on ice. After
washing, samples were incubated for an additional 30 min with 2 ug FITC-avidin or Texas
Red-avidin (0°C), washed twice, reconstituted in HBSS/NaN3/BSA (0°C) and the fluores-
cencewas measured on a flow cytometer (Epics 753 ; Coulter Electronics, Hialeah, FL). The
fluorescence intensities of 10,000 cells were determined for each sample. Viable lymphocytes
were selected by gating on forward angle and 900C light scatter. Hence, mean fluorescence
intensity (MFI) represents the average fluorescence value for viable lymphocytes in a sample.
Other Cell Surface Molecules.
￿
A similar double-labeling approach was used for measuring
class I MHC antigens on the flow cytometer. After incubation and isolation of viable cells,
samples were cleared of surface Fc receptor-bound Ig by consecutive 1-min washes in DNP-
saturated MEM and pH 4 MEM (see Results). Each sample of 106 cells was then probed
with anti-class I antibody (anti-K' Dd, 34-1-2S or anti-Dd, 34-5-8S) for 30 min on ice. The
second incubation was carried out with FITC-goat anti-mouse IgG followed by measurment
on the flow cytometer. Measurement of sIgM was accomplished with a single 30-min incuba-
tion with a FITC-goat anti-mouse IgM antibody. All antibodies used in flow cytometry ex-
periments were airfuged before use to remove aggregated materials.
Cell Cycle Characterization by Flow Cytometry.
￿
Propidium iodide was used to stain the DNA
of intact nuclei from hypotonically lysed cells, similar to the assay reported by DeFranco et
al. (29). B lymphocytes from BALB/c mouse spleen were incubated for 48 h in 24-well culture
plates (5 x 106 cells/ml). Colcemid (30 ng/ml) was added at 24 h to prevent completion of
M phase. The cells were washed, centrifuged over Ficoll (specific gravity 1 .090), removed
from the interface, and washed twice. To each sample of 106 cells, 50 pg/ml propidium io-
dide, 0.1 % sodium citrate, and 0.1% NP-40 were added followed by flow cytometric analysis.
Cell populations were categorized according to whether DNA was diploid (Go or G1 phases),
intermediate (S phase), or tetraploid (G2 or M phases).
Thymidine Incorporation.
￿
Lymphocyte cultures were established in 96-well plates; 105 cells
in 200 ul of DME/5o7o FCS containing 0.05 mM 2-ME. After 36 h, 50 ul [3H]TdR (20
gCi/ml MEM) was added to each well and allowed to incubate an additional 12-16 h before
harvesting (Titertek cell harvester).
Results
Binding Characteristics of IgE-Antigen Complexes vs. Monomeric IgE to Lymphocyte FcsR
IgE-Antigen Complexes Resist Acid Elution From FccR. Before quantitating Fc&R sites
by .25I-IgE labeling in vitro, it was necessary to remove IgE from the lymphocyte
surface. Cell-bound monomeric Ig is sensitive to removal by acid (30, 31) and ex-
posure of lymphocytes to low pH solutions does not appear to affect subsequent IgE
binding to FcFR (32). Moreover, we have observed no differences in specific
1251_
IgE binding to B cells previously exposed to either pH 4 or pH 7 solutions.
Greater than 95% of monomeric IgE was removed from BALB/c spleen cells by
a 1-min wash in pH 4 MEM (Fig. 1). However, if anti-DNP IgE was complexed
with DNP-OVA, N80 ° Jo of the IgE remained bound to lymphocyte surfaces after
the acid wash at pH 4.0, and even solutions of lower pH did not completely remove
the IgE-antigen complexes. This resistance to acid elution was dependent on an-574
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FIGURE 1 . IgE-antigen com-
plexes resist acid elution from
Fcc .R . 5 x 10 6 BALB/c spleen
cellswere incubated in PAB with
5 gg/ml of IgE plus 125I-IgE in
the absence or presence ofvary-
ing concentrations of DNP-
OVA. After 2 h, all samples were
washed inPAB (4°C), incubated
for 1 min in 0.5 mlMEM(4°C)
of varying pH, washed in 4 ml
MEM (pH 7.0), and centri-
fuged over oil . Data points rep-
resent meansofduplicatesam-
ples . As for all 1251-IgE- Fc6R
binding experiments, nonspeci-
fic cell-associated radioactivity
(cpm of 125I-IgE bound in the
presence of 200gg/ml IgE) was
subtracted from all values .
tigen concentration . In the presence of 5 wg/ml of IgE, optimalDNP-OVA concen-
trations were 1-10 gg/ml, thus approximating 1 :1 molar concentrations ofIgE and
antigen . Comparable results were obtained with 10 gg/ml of IgE.
Reversal ofAcid Resistance of FcER-boundIgEAntigen Complexes by Competitive Elution
with Free DNP . To remove IgE-antigen complexes from lymphocyte FceR while
avoiding the potentiallyharmful effects ofvery lowpH solutions, we adapted acom-
petitive elution approach using saturated solutions of dinitrophenol . As illustrated
in Fig. 2, exposure to free DNP inMEM had little effect on the binding ofmono-
meric IgE to nascent FceR on lymphocytes or the ability to elute the IgE at acid
pH (group II vs . group I) . On the other hand, the acid resistance ofFceR-bound
FIGURE 2 .
￿
Reversal of acid resistance of Fc&R-bound IgE-antigen complexes by competitive elu-
tion with freeDNP . BALB/c spleen cells were treated in a similarmanner to those of Fig. 1 except
that groups 11 and IV also were washed for 1 min in DNP-saturated MEM (4°C) immediately
before the 1-min incubation in 0.5 mlMEM (final pH, 4 or 7) and wash in 3 ml MEM (pH
7.0) . The data reflect means (tSE) of triplicate samples .RICHARDS ET AL.
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FIGURE 3 .
￿
IgE-antigen complexes dissociate from lymphocyte FcER more slowly than mono-
meric IgE . Unfractionated BALB/c spleen cells were exposed to 10 ug/ml IgE plus " 5I-IgE alone
or in combination with 1 jig/ml of DNP-OVA for 2 h in PAB (4°C) . After a 5 min, 4°C wash,
samples were immediately reconstituted in PAB (37°C) containing 200 pg 5/ml unlabeled IgE and
centrifuged over oil at varying times thereafter. Minimal dissociation of 12 I-IgE occurred during
the wash . After 120 min ofdissociation, excess free DNP was added to several samples that were
initially exposed to IgE plus DNP-OVA . Sampling was performed in triplicate and the means
(±SE) are shown .
IgE-antigen complexes (group III) was completely reversed by exposure to free DNP
(group IV), indicating that such exposure succeeded in competitively eluting the
antigen from the cell-bound IgE . These results were confirmed in another experi-
ment in which cell-bound IgE was quantitated with 1251-GAME instead of 125I-IgE
(not shown) .
IgE-Antigen Complexes Dissociate from Lymphocyte FeER More Slowly than Monomeric
IgE . The apparent increased avidity of IgE-antigen complexes for FcER is further
illustrated by the comparative '25I-IgE dissociation curves in the absence and pres-
ence of antigen (Fig. 3) . The dissociation half-times at 37°C from unfractionated
BALB/c splenic lymphocytes, taken from the terminal linear portion of the curve
(mean of three experiments), were 440 min for IgE-antigen complexes vs . 8 min
for monomeric IgE. Dissociation half-times from isolated B cells were 325 and 7
min, respectively (two experiments; not shown) . A similar patternwas observedwhen
the experiment was performed at 4°C, except that the dissociation rates were com-
mensurately longer for both monomeric and complexed IgE . Competitive elution
of antigen from the complexed 125I-IgE by addition ofDNP after 120 min markedly
increased the dissociation rate, approaching that of the monomeric form (Fig . 3) .
This furtherdemonstrates the reversibility ofthe bindingphenomenon and eliminates
internalization ofthe IgE-antigen complex as an explanation for its exceedingly slow
dissociation rate . Ligand/receptor internalization, however, might account for the
residual5% of the original cell-associated radioactivity that remained 1 h after addi-
tion ofDNP .576
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FIGURE 4 . FcFR expression by
mouse lymphocytes is more effi-
ciently induced by IgE-antigen com-
plexes . Bcell-enriched splenocytes
were incubated for 18-24 h in me-
dium alone or together with IgE (10
wg/ml) without or with 1 tlg/ml
DNP-OVA . After removal ofIgEby
a free DNP/acid wash, FcER were
quantitated by exposure to 10 gg/ml
monomeric IgE plus 1211-1gE for
2 h at 4°C . Each data point repre-
sents themean (±SE) of triplicate
samples . This experiment was per-
formed two times with bothB cell-
enriched and unfractionated spleen
cell populationswith similar results .
IgE-antigen complexes did not appear to bind to additional sites sincelymphocyte-
bound 1251-IgE was essentially equivalent in the presence or absence of antigen as
determined at the end of the initial 2-h exposure . However, presumably because
of multiple crosslinked 1251-IgE-antigen monomers, cell bound radioactivity was
slightly higher when the molar concentrations of IgE andDNP-OVA were equiva-
lent (not shown) . Removal of these complexes by addition of free DNP just before
measurement of radioactivity reduced cell-associated cpm to the level ofthose samples
incubated in the absence of DNP-OVA.
Modulation of Cell Surface Molecules By IgEAntigen Complexes
FccR Expression by Mouse Lymphocytes Is More Efficiently Induced by IgE-Antigen Com-
plexes. In addition to increasing the binding avidity of IgE to its receptor, forma-
tion of complexes with antigen increased the efficiency with which IgE induced the
expression of FceR molecules on lymphocytes (Fig. 4) . Thus, -30-fold less antigen-
complexed IgE than free IgE induced equivalent peak levels ofFCER expression by
cultured lymphocytes . This increased efficiency of IgE-antigen complexes vs . free
IgE (Fig . 4) was consistently observed in three experiments with either isolated B
cells or unfractionated lymphocytes. Significantly, exposure ofcells to DNP-specific
FIGURE 5 .
￿
IgE-antigen complexes, but not mono-
meric IgE, induce Ia antigen expression by BALB/c
B cells . After an 18 h incubation (37°C) with either
medium alone, LPS (50 jig/ml), monomeric IgE (10
~Lg/ml), or IgE-DNP-OVA complexes, B cells were
washed and stained for I-A antigens . The latter was
accomplished by successive 30-min, 4°C exposures
to biotin-MKD6 (anti-I-Ad) antibody and Texas
red-avidin separated by a single wash . The change
in flowcytometric measurements ofI-A antigen den-
sity is depicted in a typical histogram .RICHARDS ET AL.
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TABLE I
IgE-Antigen Complexes Stimulate B Lymphocyte Ia Expression in the
Absence of T Cells and Macrophages
BALB/c mouse spleen cells (unfractionated, T cell-depleted, orT cell-and macrophage-depleted)
or murine lymphoma cells (M12.4.5) were induced with IgE, IgE-antigen complexes, or LPS
for 18-24h at 37°C . Cells were stained for sI-A using theapproach outlined in Materials and
Methods and Fig 5 . For each sample, 10,000 cells were analyzed .
IgGI, IgA, or IgMmAbs either in monomeric or antigen-complexed form did not
affect the expression of FCSR by cultured spleen cells .
IgEAntigen Complexes, but not Monomeric IgE, Induce Ia Antigen Expression by BALBIc
B Cells . The enhanced expression of FceR induced by IgE-antigen complexes in-
spired an examination ofother cell surface antigens . As shown in Fig. 5, IgE-antigen
complexes induced increased expression of class II MHC (Ia) antigens on the sur-
face ofBALB/c B lymphocytes . Thus, I-Ad antigen expression was enhanced by ex-
posure to IgE-antigen complexes, and to a similar magnitudeoccurring in response
to 50 ltg/ml of LPS. Conversely, exposure to monomeric IgE did not increase Ia
antigen expression . Maximum increasesof la-antigen expression were observed after
12-44h of incubation with IgE-antigen complexes (data not shown) . A 4-h incuba-
tion with IgE-antigencomplexes resulted in a negligible change in surface la, whereas
significant induction of surface Ia occurred after 4 h incubation with LPS and this
increased progressively through 44 h.
IgE-Antigen Complexes StimulateB Lymphocyte la Expression in the Absence ofT Cells and
Macrophages . IgE-antigen complexes, in contrast to IgE alone, produced a modest
increase of I-A expression in unfractionated splenic lymphocytes, and to a much
FIGURE 6 .
￿
Both FceR and I-A
expression by mouseBlympho-
cytes are induced by IgE-
antigen complexes of similar
composition . The in vitro re-
sponse ofFceR andI-Aantigen
expression to monomericIgE or
IgE-DNP-OVA complexes are
compared in B lymphocytes .
The data for FceR expression
arereproduced from Fig .4. Cell
surface I-A were measured as
outlined in the legend for Fig .
5 . Incubations were carriedout
for 18-24 h .
Surface I-A expression (percent increase MFI)
18-24 h
induction (37°C) by :
Un£ractionated
spleen cells
T cell-depleted
spleen cells
T cell- and
macrophage-
depleted
spleen cells
M12.4 .5
cells
IgE (10 gg/ml) 5 1 17 2
IgE (10 wg/ml) +
DNP-OVA (1 wg/ml) 11 143 145 - 1
LPS (50 wg/ml) 80 110 277 35578
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FIGURE 7 .
￿
Murine B cells expressing a high density of FceR in response to IgE-antigen com-
plexes also express a high density of Ia antigens. After an 18-h incubation period, B cells were
washed in free DNP/acid to remove surface Ig . Lymphocytes (-9570 B cells) were then exposed
to IgE for 1 h (4°C) while biotinylated MKD6 antibody was included during the last 30 min
ofthe first labeling period . After washing, the cells were exposed to GAME andTexas red-avidin
for an additional 30 min, washed,andanalyzed by flow cytometry. Crossreaction ofFITC-GAME
with other cell surface molecules (i .e ., in the absence of IgE) was significant but did not present
a major interference in this experiment .
greater extent in B cell-enriched populations (Table I) . This lower level of I-A ex-
pression in unfractionated spleen cells also was observed when gating the analysis
on the more strongly I-A+ cells . Macrophages did not contribute to the effects of
IgE-antigen complexes on B cell surface Ia expression since splenic lymphocytes
depleted of bothT cells and macrophages displayed similar increases of I-A expres-
sion as observed for the T cell-depleted lymphocytes (Table I) . I-A expression was
enhanced by LPS in all spleen cell populations . Interestingly, the FcFR-bearing mu-
rine lymphoma cell line, M12.4.5, did notdisplay increased Ia expression in thepres-
ence of IgE-antigen complexes, whereas LPS induced a modest response (Table I) .
Both FceR and Ia Expression by MouseBLymphocytes Are Induced by IgEAntigen Com-
plexes ofSimilar Composition . Induction of class II MHC antigen expression more
vividly demonstrates the discrepancy between the effects of monomeric and com-
plexed IgE (Fig . 6) . Although half-maximal stimulation ofB cell Fc&R expression
required 3 ug/ml of monomeric IgE, a concentration far exceeding that normally
found in vivo, surface I-A expression was only modestly increased by as much as
100 wg/ml of monomeric IgE . Conversely, in the form of IgE-antigen complexes,
the IgE concentration-response curve for surface Ia expression paralleled that ofFceR
expression (Fig. 6) .
Murine B Cells Expressing a High Density of FCSR in Response to IgEAntigen Complexes
Also Express a High Density of Ia Antigens. Contour plots of cells stained for FceR
and surface Ia antigens (Fig. 7) show that while LPS stimulates only sIaexpression,
IgE-antigen complexes induced expression ofboth cell surface markers and, moreover,
B cells that exhibited higher levels of FcFR also expressed more surface Ia.
Antigen-complexed IgE, but not IgGI, Selectively Modulates Ia Expression Regardless ofAn-
tigen Specificity . DNP-specific IgE was equally effective in stimulating I-A expres-
sion when complexed with either DNP-OVA or DNP-BSA (Table II) . Moreover,
induction of I-A antigen expression was not limited to IgE ofDNP specificity or
any other unique quality of that particular mAb . Thus, ragweed-specific IgE in-
duced surface Ia expression on B cells when complexed with 0.5 to 5 ug/ml of rag-
weed antigen, but not in its monomeric form or in the presence of DNP-protein .RICHARDS ET AL.
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TABLE II
Antigen-complexed IgE, But not IgGI, Selectively Modulates la Expression
Regardless of Antigen Specificity
BALB/c splenic B cells were induced with antibody, antigen-antibody complex-
es, or LPS for 18-24 h at 37°C . Cells were stained for sl-A using the approach
outlined in Materials and Methods and Fig. 5. Using a similar procedure, class
I MHC antigens were labeled by exposing the cells to anti-Dd or anti-KdDd an-
tibodies, washing the cells, and exposing them to FITC-GAMG antibody .
FITC-anti-IgM was used to label sIgM. For each sample, 10,000 cells were
analyzed .
I-A-associated MFI was minimally altered by incubation with <5 gg/ml of ragweed
antigen (data not shown).
The inducibleexpression of la antigens by antigen-complexedantibodies appears
to be dependent on IgE. Thus, amodest increase of I-A-associated fluorescence was
discernable after a 24-h incubation of B cells with monomeric DNP-specific IgGI
(20-1,000 ltg/ml) but, unlike IgE, further enhancement did not occur in the pres-
ence of varying amounts of DNP-OVA (Table II).
The effects of IgE-antigen complexes on other cell surface molecules also were
tested by flow cytometry (Table II). LPS (50 gg/ml) reduced the expression of sIgM,
while IgE-antigen complexes produced little variation in s1gM density on B cells
labeled by a FITC-goat anti-mouse IgM antibody. Class I antigenexpression, using
anti-KdDd (34-1-2S) or anti-Dd (34-5-8S) antibodies as the initial probes, revealed
that a small enhancement of fluorescence was achieved with LPS but no change oc-
curred in samples treatedwith IgE-antigen complexes. Similar results were obtained
regardless of which anti-class I antibody was used as the initial probe.
The binding of biotinylated anti-IgMb (IgGI, AF6-78.25) and anti-I-A' (IgG2a,
10.3.6) to T cell-depleted splenocytes was tested by flow cytometry after a 16-h incu-
bation. Neither antibody bound sufficiently to exceed background fluorescence and
no change in fluorescence was observed in cells incubated with either IgE-antigen
complexes or LPS. These results further demonstrate the specificity of the la re-
sponse and indicate that binding of MKD6 and 14.4.4 antibodies to Fcy receptors
is not responsible for the enhanced fluorescence signal in IgE-antigen-treated cells.
18-24 h
induction (37°C) by:
Surface Molecule Expression
(percent increase MFI)
Antibody (wg/ml) Antigen (pg/ml) I-A H-2d IgMd
IgE anti-DNP (10) None 0 0 -8
DNP-OVA (1) 158 -4 -13
DNP-BSA (1) 157
IgE anti-ragweed (5) None 0
Ragweed (5) 76
IgGI anti-DNP (10) None 27
DNP-OVA (1) 19
IgGI anti-DNP (1,000) None 5
DNP-OVA (10) 8
LPS (50 gg/ml) 110 14 - 77580
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FIGURE 8 .
￿
IgE-antigen complexes, but not IgE or antigen alone, induce I-A and I-E antigen
expression by B cells . B lymphocytes were incubated with either media alone, monomeric IgE
(10 wg/ml), DNP-OVA (1 gg/ml), IgE-DNP-OVA complexes or LPS (50 Vg/ml) for 18-24 h at
37°C . Biotinylated MKD6 or 14.4 .4 (anti-I-Ed) antibodies were used to label I-A or I-E, respec-
tively, usingthe approach outlined in MaterialsandMethodsand the legend ofFig. 5 . The values
are single determinations representing analysis of 10,000 cells each . Similar results were obtained
in other experiments.
IgEAntigen Complexes, ButNotIgEorAntigen Alone, InduceI-A andI-EAntigen Expres-
sion ByB Cells. As shown in Fig . 8, neither monomeric IgE norDNP-OVA alone
affected class II antigen expression (groups II andIII) . Conversely, IgE-antigencom-
plexes, like LPS, enhanced the expression of surface I-E antigens in a manner that
paralleled surface I-A enhancement (groups IV and V) .
IgEAntigen ComplexesDo Not StimulateDNA Replication.
￿
Because increased expres-
sion of surface la is often associated with B cell activation, other parameters that
might reflect B cell activation processes by IgE-antigen complexes were examined .
Increasing cell size is an early indicator of cell activation (33) . When monitoring
cell volume by either a Channelyzer(Coulter Electronics) or by forward angle light
scatter on the flow cytometer, LPS produced significant cell enlargement on both
scales, whereas only nominal increases of cell size were detected after overnight in-
cubation with IgE-antigen complexes (data not shown) . Cell cycle was determined
by labeling B cell nuclearDNA with propidium iodide and the fluorescence mea-
sured by flow cytometer. The percentage of cells in either the S (intermediate) or
G2/M (tetraploid) phases were combined, representative of cell cycle activation (Fig.
9) . No cell activation was observed after 48 h of incubation with monomeric orcom-
plexed IgE, while LPS stimulated a large fraction of cells to exceed diploidDNA.
Similarly, [3H]TdR incorporation by B lymphocytes was unaffected by incubation
with either monomeric or complexed IgE, whereas LPS stimulated substantial in-
creases of [3H]TdR uptake (Fig . 9) .
Discussion
The principal findings of the experiments described herein are: (a) the existence
of differences between monomeric and complexed IgE with regard to their bindingRICHARDS ET AL .
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FIGURE 9 . IgE-antigen com-
plexes do not stimulate DNA
replication . B cells were isolated
from BALB/c mouse spleen and
incubated with either media
only, 10 jig/ml IgE, IgE-DNP-
OVA, or 50 ug/ml LPS for 48 h
at 37°C . Incorporation of thy-
midine was measured by puls-
ing the cells with [3H]TdR
(20 gCi/ml) during the last 12 h
ofincubation before harvesting.
Cell cycle was determined by
quantitating propidium iodide
incorporation into nuclearDNA
on the flow cytometer. Cells that
contained more than diploid
DNAwere regarded as entering
the cell cycle . Both experiments
were repeated, resulting in sim-
ilar findings .
to, and induction of, FcFR sites on mouse spleen lymphocytes and (b) the potent
stimulation ofB cell surfaceIa antigen expression caused by IgE-antigen complexes
in vitro .
Monoclonal IgE bound to splenic lymphocytes with greater avidity when com-
plexed with its specific antigen. This is illustrated by the resistance of IgE-antigen
complexes to elution at acid pH and by the reversal of such acid resistance by com-
petitive elution ofantigen from the complexes byDNP-saturatedMEM (Figs . 1 and
2) . This marked difference in apparent binding affinity of monomeric and oligo-
meric IgE can be explained, at least in part, by differing dissociation rates (Fig. 3) .
However, direct comparisonsof these rates aredistorted because dissociation of both
monomeric and complexed IgE was at least biphasic . Such behavior previously has
been noted for monomeric IgE. Vander-Mallie et al . (23) reported that after addi-
tion of excess unlabeled IgE, 25% ofmonomeric 1251-IgE immediately dissociated
from lymphocytes followed by a slower dissociation half-time of-67 min at 0°C .
Our results for monomeric IgE dissociation at 4°C were similar to these findings
(datanot shown). Thereason forthebiphasic decline ofmonomeric IgE is unknown
but possibly represents FcFR heterogeneity, cooperativebinding events, or a combi-
nation thereof . The fact that lymphocyte-bound IgE molecules are not displacable
by moderate concentrations of yt-, Yea-, Y2b- or tt-Ig (11, 23) tends to rule out IgE
binding to other FcR as the cause for its biphasic dissociation .
In the presence of specific antigen, IgE dissociated from lymphocyte FcFR at a
more highly variable rate, ranging from an immediate loss of 1251-IgE much like
the monomer, to a substantially slower rate after 90 min (Ti/2 >400 min at 37°C) .
An additional explanation for this multiphasicdissociation ofcomplexedIgE might
be the variable IgE valence of the IgE-antigen complexes . An oligomer containing
several IgE molecules capable of binding to lymphocyte FceR would be expected
to bind with greater avidity than an IgE-antigen complex comprising a single IgE
molecule. SegalandHurwitz(34) reported that the avidityofcrosslinked IgGoligomers
to FcyR on lymphocytes increased with the size of the IgG complex. However, the582
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decrease in free energy accompanying binding of the monomer was only slightly
less than for the dimer, and so on for larger complexes. Such behavior was explained
by steric hindrance, negative cooperativity, and/or a loss of entropy associated with
unfavorable spatial arrangements of the oligomeric Ig in relation to the receptor.
Hence, because of these idiosyncratic events, the increased avidity of FceR binding
of IgE-antigen complexes cannot be quantitatively predicted. Nonetheless, using
antibody-antigen complexes that more closely approximate natural conditions than
the affinity crosslinked oligomers used by Segal and Hurwitz (34), we obtained similar
apparent increases of FceR avidity. It should be noted that these effects ofIgE-antigen
complexes could reflect either true increases of binding avidity by Fc8R or stabiliza-
tion of FceR molecules on the cell surface due to crosslinking, or combinations
thereof.
In addition to their effects on direct binding to nascent FceR, IgE-antigen com-
plexes displayed significantly different properties than monomeric IgE in terms of
inducing new FceR and other cell surface molecules on lymphocytes. Thus, IgE-
antigen complexes are -30-fold more efficient than monomeric IgE in inducing FceR
expression, although maximum FccR levels are equivalent in both cases (Fig. 4).
The increased potency of IgE-antigen complexes for stimulating FceR could be ex-
plained by its increased binding avidity and consquential interference with FceR
recycling. Indeed, from experiments with murine B cell hybridoma lines, Lee et al.
(35) reported that by binding to the receptor, monomeric IgE blocks FceR cleavage
and subsequent release from the cells. Alternatively, by prolonged association with
FceR, IgE-antigen complexes might provide a stronger signal for inducing new
receptor synthesis. Previous reports that protein synthesis inhibitors block IgE-induced
FceR expression (19, 36) are consistent with this possibility. Nonetheless, the avail-
able data do not permit a distinction between these possibilities as yet.
The novel, and unexpected, observation in these studies was the striking induc-
ibility of B cell surface class II MHC molecules by IgE-antigen complexes. Previous
descriptions of a direct influence of IgE-antigen complexes on B lymphocyte la an-
tigens are unknown to us. Virgin et al. (24) examined the effect of immune com-
plexes of various Ig isotypes on IFN-y-induced la expression on peritoneal macro-
phages and found that complexes containing either IgG or IgE inhibited such induction
in a concentration-dependent manner, provided such complexes were attached to
a solid phase support . Complexes of IgA or IgM had no such effects. However, pos-
sible direct effects ofeither monomeric or complexed IgE, in the absence of IFN-y,
on la expression by peritoneal macrophages were not reported. In the present studies,
we found that IgE-antigen complexes induced la expression predominantly on B
cells in splenic lymphocyte populations; macrophages did not appear to participate
(Table I). However, we have not performed similar analyses with peritoneal macro-
phages. Nonetheless, there is no evidence to suggest that FceR must serve the same
function or be affected in the same ways in different cell types. Indeed, IFN-y, which
induces la expression on peritoneal macrophages, inhibits IL-4-induced expression
of la on murine B cells (37). IgE-antigen complexes did not block the enhanced Ia
expression caused by supernatants obtained from PMA-stimulated EL4 cell cultures
(not shown) and soluble IgG complexes had no effect on la antigen expression by
B cells (Table II). Hence, the findings of Virgin et al. (24) regarding IgE effectsRICHARDS ET AL.
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on peritoneal macrophages seem to bear little relationship to ourresultswith Blym-
phocytes.
The nature of the interaction between IgE, antigen, and spleen cells to increase
B lymphocyte la expression is unknown. Because T cell depletion resulted in an
enhanced B cell la-associated fluorescence signal (Table I), it is unlikely that T cells
or release ofT cell-derived lymphokines contributes to the enhanced signal. Thus,
as reported for anti-IgM antibody (38), the IgE-antigen complex-stimulated increase
of B cell Ia expression is most likely T cell independent. Further, the la response
to IgE-antigencomplexes observed in theTcell-depleted population was maintained
when macrophages also were removed. Additionally, indirect evidence points to the
autonomy of B cells in responding to IgE-antigen complexes. The population of B
cells with the largest Ia antigen response to IgE-antigen complexes also expressed
the highest concentration of Fc&R (Fig. 7). Moreover, the increased expression of
these two cell surface molecules paralleled one another in response to increasing con-
centrations of IgE in the presence of antigen (Fig. 6). It has been shown that IgE-
induced Fc&R expression by B lymphocytesrequires no accessory cells (19, 37). Hence,
in light of the apparent accessory cell-independence of the B cell Ia response, it is
interesting to consider the effect of incubating M12.4.5 cells with IgE-antigen com-
plexes (Table 1). The M12.4.5 lymphoma cell line has FccR sites that are inducible
by both IgE (39) and IgE-antigen complexes (not shown). However, in spite of a
significant la response to LPS, IgE-antigen complexes have a negligible effect on
M12.4.5 Ia expression. This lack of response might reflect either a need for other
cells/factors, the state of activation exhibited by M12.4.5 cells, or a defect in pro-
cessing the message produced by the IgE-antigen-FccR interaction. Further study
is needed to find more direct evidence forthe role of accessory cells in the mediation
of IgE-antigen-stimulated B cell la expression.
The cellular processes that are ultimately governed by IgE to increase the expres-
sion ofB cell la andFcsR remain to be elucidated. Lee et al. (35) showed that mono-
meric IgE increases B cell hybridoma FcsR by binding to the receptor and decreasing
its turnover. A similar mechanism also might explain the increased expression of
Ia antigens. Bonnefoy et al. (40) recently reported that FcsR and HLA-DR antigens
are spatially associated on human B cell membranes, based on the binding activity
of two mAbs. Further, FcsR and the a and R chains of HLA-DR were found to be
complexed noncovalently in the membrane. It follows that if IgE-antigen complexes
bind to FcsR, thus stimulating its expression by decreasing its degradation, then
Ia antigens would respond in parallel. However, this argument is invalidated by the
lack of effect of monomeric IgE on la antigen expression. Additionally, if FcsR and
la antigens were spatially associated, then FcsRbound IgE-DNP-OVA complexes
might be expected to sterically inhibit the binding of anti-I-A and anti-I-E anti-
bodies. Nonetheless, similar increases of la-associated MFI were observed whether
or not B cell-bound IgE was removed before Ia quantitation. Hence, transmem-
brane communication likely is required for FcsRmediated control of la antigen ex-
pression. IgE-antigen complexes stimulate Ia antigen and FcsR expression in par-
allel. By extrapolation, if complexation of IgE is required to modulate Ia mRNA,
asimilar mechanismmight be invoked for the transcriptional control ofFcsR. These
questions currently are under investigation.584
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Theimmunological protection attributed to IgE largelyhas been confined to para-
siticinfections. IgE suppressionin rodents, for example, results in an increased sus-
ceptibility to Shistosoma mansoni infection (41). Augmenting B cell la antigen expres-
sion would clearlyplay an importantrole in IgE-mediated resistance to these infections.
Variation of B cell surface Ia likely would affect interaction with T lymphocytes.
It is known that B cells expressing low levels of sIa antigens are less effective targets
for helper T cells than B cells expressing more surface Ia (42). Moreover, B cell re-
quirement for la-restricted T cell help occurs before B cell activation and entry into
the S phase (43); i.e., the stage in which splenic B cells normally reside. Hence, B
cell FCSR are maximally expressed at a time when la antigens serve an important
role in elicitingT cell help. Further, despite the lack ofeffect on B cell size, cell cycle
activation andthymidine incorporation, IgE-antigencomplexes might initiate a signal
that would ultimately give rise to cell mitogenesis. In the presence of a costimulant,
such as a T cell-derived lymphokine, B cells could be induced to mature and repli-
cate. Higher levels ofT cell lymphokines might be expected in response to improved
T cell interaction with surface Ia-enhanced B cells. The high percentage of FCSR+
cells and the highly potent surface Ia augmentation brought about by IgE-antigen
complexes suggest that this Ig system might play a broader role in countering for-
eign antigens.
Summary
Murine monoclonal IgE interacts with BcellsofBALB/c mouse spleen with greater
efficiency in the presence of its specific antigen. Complexes of anti-DNP IgE and
DNP-OVA not only resist elution from B lymphocytes by acid but have a substan-
tially longer dissociation half-time when compared with monomeric IgE (440 vs.
8 min, respectively). Further, these IgE-antigen complexes induce FCSR expression
in lymphoid cells more efficiently than IgE alone. Maximum levels of B cell FCSR
were observed after a 24 h incubation with 1 jig/ml IgE in the presence of 1 hg/ml
DNP-OVA, while 30 wg/ml monomeric IgE was needed to elicit a similar increase
of FceR expression.
Most importantly, overnight incubation of B cell-enriched BALB/c spleen cells
with IgE-antigen complexesresulted in an augmented membrane expression ofclass
II MHC antigens. B cell surface expression of both I-A and I-E antigens responded
to a comparable level after incubation with IgE-antigen complexesbutdid not occur
in response to either IgE or antigen alone. The enhanced sIa expression occurred
in parallel to IgE-antigen concentrations that gave rise to FCSR hyperexpression.
Moreover, double staining for FCF .R and surface Ia antigen shows that B cells ex-
hibiting the highest density of Fc&R also demonstrated the most surface I-A, sug-
gesting that B lymphocytes are autonomous in their response to IgE-antigen com-
plexes. Changes in class I MHC or sIgM were notobserved afterovernight incubation
with IgE and antigen. These results demonstratethe importance ofIgE-antigen com-
plexes for intercellular signalingandfurther suggest that theIgE system playsabroader
role in immune response than it has generally been credited.
Theauthorsgratefully acknowledge Dr. CarolCowing forvaluable discussions andDr. Donald
Mosier forcritical review ofthe manuscript. We thankCharlesSylvesterandEdward Kloszewski
for their technical assistance with flow cytometry. We thank Janet Czarnecki for expert
secretarial assistance in preparation of this manuscript.RICHARDS ET AL.
￿
585
Receivedforpublication 7 March 1988 and in revisedform 18 April 1988.
References
1. Brown,J. C., D. G. Dejesus, D.J. Holborow, and G. Harris. 1970. Lymphocyte-mediated
transport of aggregated human y-globulin into germinal center areas of normal mouse
spleen. Nature (Loud.). 228:367 .
2. Gonzalez-Molina, A., and H. L. Spiegelberg. 1977 . A subpopulation of normal human
peripheral B lymphocytes that bind IgE.J. Clin. Invest. 59:616.
3. Hellstrom, U., and H. L. Spiegelberg. 1979. Characterization of human lymphocytes
bearingFc receptors for IgEisolated from bloodand lymphoid organs. Scand. J. Immunol.
9:75.
4. Fritsche, R., and H. L. Spiegelberg. 1977 . Fc receptors for IgE on normal rat lympho-
cytes. J. Immunol. 121:471 .
5. Sterk, A. R., andT. Ishizaka. 1982. Bindingproperties ofIgEreceptors on normal mouse
mast cells. J. Immunol. 128:838.
6. Spiegelberg, H., G. Boltz-Nitulescu, J. Plummer, andF. Melewica. 1983. Characteriza-
tion of IgE Fc receptors on monocytes and macrophages. Fed. Proc. 42:126.
7. Capron, M., A. Capron, J. -P. Dessaint, G. Torpier, S. G. O. Johansson, and L. Prin.
1981 . Fc receptors for IgE on human and rat eosinphils. j Immunol. 126:2087.
8. Yodoi, J., and K. Ishizaka. 1979. Lymphocytesbearing Fc receptors forIgE. I. Presence
of human and rat T lymphocytes with Fcs receptors. J. Immunol. 122:2577.
9. Yodoi,J., T. Ishizaka, andK. Ishizaka. 1979. LymphocytesbearingFc-receptors for IgE.
Il. Induction of Fcs-receptor bearing rat lymphocytes by IgE. J . Immunol. 123:455.
10 . Yodoi, J., andK. Ishizaka. 1979. Lymphocytesbearing receptorsfor IgE. III. Transition
of FcyR(+) cells by IgE. f. Immunol. 123:2004.
11 . Chen, S. S., J. W. Bohn, F. T. Liu, and D. H. Katz. 1981. Murine lymphocytes ex-
pressing Fc receptors for IgE (FcFR). I. Conditions for inducing FCCR' lymphocytes and
inhibition oftheinductiveevents by suppressive factor of allergy (SFA).J ImmunoL 127:166.
12 . Katz, D. H. 1984. Regulation of the IgE system: experimental and clinical aspects. Al-
lergy (Copenh.). 39 :81.
13 . Spiegelberg, H. L., R. D. O'Conner, R. A. Simon, and D. A. Mathison. 1979. Lympho-
cytes with immunoglobulin E. Fc receptorsin patients with atopic disorders. J . Clin. In-
vest. 64:714.
14 . Yodoi, J., M. Hirashima, and K. Ishizaka. 1980. Regulatory role ofIgE-binding factors
from rat T lymphocytes. II. Glycoprotein nature and source of IgE-potentiating factor.
J. Immunol. 125:1436.
15 . Hirashima, M., J. Yodoi, and K. Ishizaka. 1980. Regulatory role ofIgE-binding factors
from rat T lymphocytes. III. IgE-specific suppressive factor with IgE-binding activity.
f Immunol. 125:1442.
16. Yodoi, J., M. Hirashima, K. Ishizaka. 1981. Lymphocytesbearing Fc receptors for IgE.
V. Effect of tunicamycin on the formationof IgE-potentiating factor andIgE suppressive
factor by Con A-activated lymphocytes. f. Immunol. 126:877.
17 . Uede, T., K. Sandberg, R. Bloom, and K. Ishizaka. 1983. IgE-binding factors from mouse
T lymphocytes. I. Formation of IgE-binding factors by stimulation with homologous
IgE and interferon. f. Immunol. 130:649.
18. Ishizaka, K., J. Yodoi, M. Suemura, and M. Hirashima. 1983. Isotype-specific regula-
tion of the IgE response by IgE-binding factors. Immunol. Today. 4:192 .
19. Marcelletti, J. F., and D. H. Katz. 1984. FcFR' lymphocytes and regulation of the IgE
antibody system. 1. Anewclassof molecules, termed IgE-induced regulants(EIR), which
modulate FcFR expression by lymphocytes. J. Immunol. 133:2821.
20. Marcelletti, J. F., and D. H. Katz. 1984. FceR' lymphocytes and regulation of the IgE586
￿
IgE-ANTIGEN COMPLEXES ENHANCE la EXPRESSION
antibody system. II. Fc&R' B lymphocytes initiate a cascade of cellular and molecular
interactions that control FcFR expression and IgE production. J. Immunol. 133:2829.
21 . Marcelletti, J. F., and D. H. Katz. FceR' lymphocytes and regulation of the IgE anti-
body system. III. Suppressive factor ofallergy (SFA) is produced during the in vitro FceR
expression cascade and displays corollary physiologic activity in vivo.f Immunol. 133:2837.
22. Marcelletti, J. F., and D. H. Katz. 1984. FceR' lymphocytes and regulation of the IgE
antibody system. IV. Delineation of target cells and mechanisms of action of SFA and
EFA in inhibiting in vitro induction of FceR expression. J. Immunol. 133 :2845.
23 . Vander-Mallie, R., T Ishizaka, and K. Ishizaka. 1982. Lymphocytes bearing Fc receptors
for IgE. VIII. Affinity of mouse IgE for FceR on mouse B lymphocytes. J. Immunol.
128:2306 .
24. Virgin, H. W., G. F. Wittenberg, and E. R. Unanue. 1985. Immune complex effects
on murine macrophages. 1. Immune complexes suppress interferon-y induction of Ia
expression. ,I Immunol. 135 :3735.
25 . Liu, E T., J. W. Bohn, E. L. Ferry, H . Yamamoto, C. A. Molinaro, L. A. Sherman,
N. R. Klinman, and D. H . Katz. 1980. Monoclonal dinitrophenyl-specific murine IgE
antibody: Preparation, isolation, and characterization.f Immunol. 124:2728.
26 . Lake, P., E. Clark, M. Khorshidi, and G. Sunshine. 1979. Production and characteriza-
tion of cytotoxic Thy-1 antibody-secreting hybrid cell lines. Detection of T cell subsets.
Eur J. Immunol. 9:875.
27 . Katz, D. H ., and D. P. Osborne, Jr. 1972. The allogeneic effect in inbred mice. II. Estab-
lishment of the cellular interactions required for enhancement of antibody production
by the graft-versus-host reaction. f. Exp. Med. 136 :455.
28 . Ly, I. A., and R. I. Mishell. 1974. Separation of mouse spleen cells by passage through
columns of Sephadex G-10. J. Immunol. Methods. 5:239.
29. DeFranco, A. L., E. S. Raveche, R. Asofsky, and W. E. Paul. 1982 . Frequency of B lym-
phocytes responsive to anti-immunoglobulin . J. Exp. Med. 155:1523.
30. Kumagai, K., T. Abo, T. Sekizawa, and M. Sasaki. 1975. Studies of surface immuno-
globulins on human B lymphocytes. I. Dissociation ofCell-bound immunoglobulins with
acid pH or at 37°C. J. Immunol. 115:982.
31 . Kulczycki, A., and H. Metzger. 1974. The interaction ofIgE with rat basophilic leukemia
cells. II. Quantitation aspects of the binding reaction. f. Exp. Med. 140:1676.
32. Conrad, D. H., and L. H. Peterson. 1984. The murine lymphocyte receptor for IgE.
1. Isolation and characterization of the murine B cell Fce receptor and comparison with
Fce receptors from rat and human. J. Immunol. 132 :796.
33. Monroe, J. G., W. L. Havran, and J. C. Cambier. 1982. Enrichment of viable lympho-
cytes in defined cycle phases by sorting on the basis of pulse-width of axial light extinc-
tion. Cytometry. 3:24.
34. Segal, D. M., and E. Hurwitz. 1977. Binding of affinity cross-linked oligomers of IgG
to cells bearing Fc receptors. J. Immunol. 118:1338.
35 . Lee, W. T., M. Rao, and D. H. Conrad. 1987 . The murine lymphocyte receptor for
IgE. IV. The mechanism of ligand-specific receptor upregulation on B cells. j Immunol.
139:1191.
36. Dacron, M., and K. Ishizaka. 1986. Induction of Fce receptors on mouse macrophages
and lymphocytes by homologous IgE. J. Immunol. 136:1612.
37 . Conrad, D. H ., T. J. Waldschmidt, W. T Lee, M. Rao, A. D. Keegan, R. J. Noelle,
R. G. Lynch, and M. R. Kehry. 1987 . Effect of B cell stimulatory factor-1 (interleukin
4) on Fce and Fcy receptor expression on murine B lymphocytes and B cell lines.f. Im-
munol. 139:2290.
38 . Cambier, J. C ., and J . G. Monroe. 1984, B cell activation. V. Differentiation signalling
of B cell membrane depolarization, increased I-A expression, Go to G, transition, and
thymidine uptake by anti-IgM and anti-IgD antibodies. J. Immunol. 133:576.RICHARDS ET AL.
￿
58'7
39. Lee, W. T., and D. H. Conrad. 1986, Murine B cell hybridomas bearing ligand-inducible
Fc receptors for IgE. J. Immunol. 136:4573.
40 . Bonnefoy, J. Y., O. Guillot, H. Spits, D. Blanchard, K. Ishizaka, and J. Banchereau.
1988. The low-affinity receptor for IgE (CD23) on B lymphocytes is spatially associated
with HLA-DR antigens . J. Exp. Med. 167 :57 .
41 . Kogoni, E. P, P. P. X. Elsas, H . L, Lenzi, and A. J. Dessein. 1986. IgE antibody and
resistance to infection. II. Effect of IgE suppression on the early and late skin reaction
and resistance of rats to Schistosoma mansoni infection. Eur. J. Immunol. 16:589.
42 . Henry, C., E. L. Chan, and D. Kodlin. 1977 . Expression and function of I region prod-
ucts on immunocompetent cells. II. I region products in T-B interactions. J. Immunol.
119:744.
43 . Andersson, J., M. H. Schreier, and F. Melchers. 1980. Tcell-dependent B cell stim. is
H-2 restricted and Ag-dependent only at resting B-cell level. Proc. Nad. Acad. Sci. USA.
78:2497.